Page last updated: 2024-08-23

bisantrene and brequinar

bisantrene has been researched along with brequinar in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Chen, J; Chen, Z; Deng, X; Dong, L; Fathi, AT; Gao, L; Gao, M; Han, L; Horne, D; Huang, H; Huang, Y; Kulkarni, P; Li, C; Li, H; Li, L; Li, W; Li, Y; Li, Z; Marcucci, G; Mulloy, JC; Müschen, M; Olsen, MJ; Prince, E; Qin, H; Qin, X; Qing, Y; Robinson, S; Salgia, R; Shen, C; Su, R; Sun, J; Tan, B; Wei, M; Weng, H; Wu, X; Wunderlich, M; Xie, J; Zhang, B; Zhao, Z1

Other Studies

1 other study(ies) available for bisantrene and brequinar

ArticleYear
Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion.
    Cancer cell, 2020, 07-13, Volume: 38, Issue:1

    Topics: Alpha-Ketoglutarate-Dependent Dioxygenase FTO; Anthracenes; Biphenyl Compounds; Cell Line, Tumor; Cell Self Renewal; Cell Survival; Enzyme Inhibitors; Gene Expression Regulation, Neoplastic; Humans; Immune Evasion; Leukemia; Membrane Glycoproteins; Molecular Structure; Protein Binding; Protein Domains; Receptors, Immunologic; U937 Cells

2020